These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23124073)

  • 21. Converging roles of caspases in inflammasome activation, cell death and innate immunity.
    Man SM; Kanneganti TD
    Nat Rev Immunol; 2016 Jan; 16(1):7-21. PubMed ID: 26655628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms regulating NLRP3 inflammasome activation.
    Jo EK; Kim JK; Shin DM; Sasakawa C
    Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gasdermin D: the long-awaited executioner of pyroptosis.
    Man SM; Kanneganti TD
    Cell Res; 2015 Nov; 25(11):1183-4. PubMed ID: 26482951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammasomes: mechanism of action, role in disease, and therapeutics.
    Guo H; Callaway JB; Ting JP
    Nat Med; 2015 Jul; 21(7):677-87. PubMed ID: 26121197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial recognition pathways that lead to inflammasome activation.
    Storek KM; Monack DM
    Immunol Rev; 2015 May; 265(1):112-29. PubMed ID: 25879288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of inflammasome activation.
    Man SM; Kanneganti TD
    Immunol Rev; 2015 May; 265(1):6-21. PubMed ID: 25879280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
    Caruso R; Warner N; Inohara N; Núñez G
    Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?
    Abais JM; Xia M; Zhang Y; Boini KM; Li PL
    Antioxid Redox Signal; 2015 May; 22(13):1111-29. PubMed ID: 25330206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-awaited merger of the pathways mediating host defence and programmed cell death.
    Blander JM
    Nat Rev Immunol; 2014 Sep; 14(9):601-18. PubMed ID: 25145756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of NLRP3 inflammasome activation.
    Sutterwala FS; Haasken S; Cassel SL
    Ann N Y Acad Sci; 2014 Jun; 1319(1):82-95. PubMed ID: 24840700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IAPs, regulators of innate immunity and inflammation.
    Estornes Y; Bertrand MJ
    Semin Cell Dev Biol; 2015 Mar; 39():106-14. PubMed ID: 24718315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
    Jakopin Ž
    J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly described pattern recognition receptors team up against intracellular pathogens.
    Broz P; Monack DM
    Nat Rev Immunol; 2013 Aug; 13(8):551-65. PubMed ID: 23846113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and regulation of the inflammasomes.
    Latz E; Xiao TS; Stutz A
    Nat Rev Immunol; 2013 Jun; 13(6):397-411. PubMed ID: 23702978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of bacteria by inflammasomes.
    von Moltke J; Ayres JS; Kofoed EM; Chavarría-Smith J; Vance RE
    Annu Rev Immunol; 2013; 31():73-106. PubMed ID: 23215645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review.
    Kaur G; Devi S; Sharma A; Sood P
    Inflammopharmacology; 2024 Oct; 32(5):3057-3077. PubMed ID: 39012431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease.
    Seidelin JB; Jensen S; Hansen M; de Carvalho Bronze MR; Cuchet-Lourenҫo D; Nejentsev S; LaCasse EC; Nielsen OH
    Clin Exp Immunol; 2024 Feb; 215(3):291-301. PubMed ID: 37583360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XIAP promotes the expansion and limits the contraction of CD8 T cell response through cell extrinsic and intrinsic mechanisms respectively.
    Thakker P; Ariana A; Hajjar S; Cai D; Rijal D; Sad S
    PLoS Pathog; 2023 Jun; 19(6):e1011455. PubMed ID: 37347786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Deubiquitinase OTUB1 Is a Key Regulator of Energy Metabolism.
    Ruiz-Serrano A; Boyle CN; Monné Rodríguez JM; Günter J; Jucht AE; Pfundstein S; Bapst AM; Lutz TA; Wenger RH; Scholz CC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K63 ubiquitination in immune signaling.
    Madiraju C; Novack JP; Reed JC; Matsuzawa SI
    Trends Immunol; 2022 Feb; 43(2):148-162. PubMed ID: 35033428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.